Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Marks

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
The Journal of Clinical Investigation|August 19, 2014
A selective microRNA-based strategy inhibits restenosis while preserving endothelial functionGaetano Santulli, Anetta Wronska, Kunihiro Uryu, et al.
International Journal of Molecular Sciences|April 17, 2025
Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 ChannelKelly Godbout, Mathieu Dugas, Steven R Reiken, et al.
The Journal of Clinical Investigation|April 17, 2002
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse modelChristopher Semsarian, Imran Ahmad, Michael Giewat, et al.
The Journal of Clinical Investigation|October 19, 2004
Blasts from the pastPaul A Insel, Stuart Kornfeld, Philip W Majerus, et al.
International Journal of Cardiology|December 3, 2014
Short-coupled polymorphic ventricular tachycardia at rest linked to a novel ryanodine receptor (RyR2) mutation: leaky RyR2 channels under non-stress conditionsJim W Cheung, Albano C Meli, Wenjun Xie, et al.
Nature Cell Biology|August 9, 2003
The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophagesBo Feng, Pin Mei Yao, Yankun Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2005
Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failureXander H T Wehrens, Stephan E Lehnart, Steven Reiken, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 18, 2011
Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytesYassine Sassi, Aniella Abi-Gerges, Jeremy Fauconnier, et al.
Stem Cell Reports|August 5, 2022
Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potentialMarissa J Stutzman, C S John Kim, David J Tester, et al.
Circulation. Arrhythmia and Electrophysiology|August 28, 2025
RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical DataAlexander Chang, Halil Beqaj, Leah Sittenfeld, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Investigation|August 19, 2014
A selective microRNA-based strategy inhibits restenosis while preserving endothelial functionGaetano Santulli, Anetta Wronska, Kunihiro Uryu, et al.
International Journal of Molecular Sciences|April 17, 2025
Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 ChannelKelly Godbout, Mathieu Dugas, Steven R Reiken, et al.
The Journal of Clinical Investigation|April 17, 2002
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse modelChristopher Semsarian, Imran Ahmad, Michael Giewat, et al.
The Journal of Clinical Investigation|October 19, 2004
Blasts from the pastPaul A Insel, Stuart Kornfeld, Philip W Majerus, et al.
International Journal of Cardiology|December 3, 2014
Short-coupled polymorphic ventricular tachycardia at rest linked to a novel ryanodine receptor (RyR2) mutation: leaky RyR2 channels under non-stress conditionsJim W Cheung, Albano C Meli, Wenjun Xie, et al.
Nature Cell Biology|August 9, 2003
The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophagesBo Feng, Pin Mei Yao, Yankun Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2005
Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failureXander H T Wehrens, Stephan E Lehnart, Steven Reiken, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 18, 2011
Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytesYassine Sassi, Aniella Abi-Gerges, Jeremy Fauconnier, et al.
Stem Cell Reports|August 5, 2022
Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potentialMarissa J Stutzman, C S John Kim, David J Tester, et al.
Circulation. Arrhythmia and Electrophysiology|August 28, 2025
RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical DataAlexander Chang, Halil Beqaj, Leah Sittenfeld, et al.
Pageof 18